Influences of Multivitamin Supplementation on Health Parameters

NCT ID: NCT03071796

Last Updated: 2017-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-07

Study Completion Date

2017-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigator will evaluate whether a liquid multivitamin supplement influences blood and vital parameters. Furthermore the investigator will establish the effects on life quality, mood and perception of stress and will characterize changes on immune system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The double-blind, randomized intervention study is conducted for 12 weeks and includes two groups (placebo versus verum) with same number of participants.

The investigator aims to determine the effects of multivitamin supplement on blood and vital parameters which includes blood pressure, pulse, heart rate, variability of heart rate, vitamin D, vitamin B12, folic acid, homocysteine, HbA1c. Furthermore the investigator will access life quality, mood and perception of stress through the following questionnaire POMS, PSS-10, SF12 \& SF36. The investigator will evaluate whether the multivitamin supplement changes the frequency of diseases like cold which represents the function of the immune system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators
double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

multivitamin supplement

liquid multivitamin supplement for 12 weeks

Group Type EXPERIMENTAL

multivitamin supplement

Intervention Type DIETARY_SUPPLEMENT

supplement includes 97 natural extracts

placebo

liquids with similar appearance and taste like multivitamin supplement for 12 weeks

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

liquids with similar appearance and taste like multivitamin supplement for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multivitamin supplement

supplement includes 97 natural extracts

Intervention Type DIETARY_SUPPLEMENT

Placebo

liquids with similar appearance and taste like multivitamin supplement for 12 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy women and men
* age between 30-60 years
* employed

Exclusion Criteria

* acute and chronic diseases (including diabetes, inflammatory bowel diseases, dementia, multiple sclerosis)
* frequent use of alcohol, drugs or cigarettes (\>5 cigarettes / day)
* use of additional supplements
* use of medications (e.g. antihypertensive medications, lipid reducers, thyroid medication)
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Martin-Luther-Universität Halle-Wittenberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kuno Hottenrott, Prof.

Prof. Dr.; University of Halle-Wittenberg, Department of Sports

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kuno Hottenrott, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Halle-Wittenberg, Department of Sports

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Halle-Wittenberg

Halle, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ILUG-201701

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparative Study Menaquinone-7
NCT01873274 COMPLETED NA
Lactation Fortification Study
NCT01747668 COMPLETED PHASE3